{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:01:43Z","timestamp":1791000103048,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Centre hospitalier universitaire Rennes","award":["2015"],"award-info":[{"award-number":["2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00262-019-02464-z","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T17:03:06Z","timestamp":1578589386000},"page":"407-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-0668","authenticated-orcid":false,"given":"Mikael","family":"Roussel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-0076","authenticated-orcid":false,"given":"Faustine","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-9553","authenticated-orcid":false,"given":"Caroline E.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-0197","authenticated-orcid":false,"given":"Todd","family":"Bartkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-5652","authenticated-orcid":false,"given":"Pauline","family":"Gravelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-7512","authenticated-orcid":false,"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6437-4189","authenticated-orcid":false,"given":"Thierry","family":"Fest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9428-8866","authenticated-orcid":false,"given":"Jonathan M.","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"key":"2464_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, Gascoyne RD (2014) The tumour microenvironment in B cell lymphomas. Nat Rev Cancer 14:517\u2013534. https:\/\/doi.org\/10.1038\/nrc3774","journal-title":"Nat Rev Cancer"},{"key":"2464_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.critrevonc.2016.10.006","volume":"108","author":"D Galati","year":"2016","unstructured":"Galati D, Corazzelli G, De Filippi R, Pinto A (2016) Dendritic cells in hematological malignancies. Crit Rev Oncol Hematol 108:86\u201396. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.10.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"2464_CR3","doi-asserted-by":"publisher","first-page":"e114345","DOI":"10.1371\/journal.pone.0114345","volume":"9","author":"CS Tudor","year":"2014","unstructured":"Tudor CS, Bruns H, Daniel C et al (2014) Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma. PLoS One 9:e114345. https:\/\/doi.org\/10.1371\/journal.pone.0114345","journal-title":"PLoS One"},{"key":"2464_CR4","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1158\/1078-0432.CCR-07-0504","volume":"13","author":"KC Chang","year":"2007","unstructured":"Chang KC, Huang GC, Jones D, Lin YH (2007) Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses. Clin Cancer Res 13:6666\u20136672. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0504","journal-title":"Clin Cancer Res"},{"key":"2464_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A et al (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"2464_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, Schmidt SV, Sander J et al (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40:274\u2013288. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.006","journal-title":"Immunity"},{"key":"2464_CR7","doi-asserted-by":"publisher","first-page":"27676","DOI":"10.18632\/oncotarget.8507","volume":"7","author":"O Marini","year":"2016","unstructured":"Marini O, Spina C, Mimiola E et al (2016) Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget 7:27676\u201327688. https:\/\/doi.org\/10.18632\/oncotarget.8507","journal-title":"Oncotarget"},{"key":"2464_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1182\/blood-2015-08-662783","volume":"128","author":"I Azzaoui","year":"2016","unstructured":"Azzaoui I, Uhel F, Rossille D et al (2016) T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood 128:1081\u20131092. https:\/\/doi.org\/10.1182\/blood-2015-08-662783","journal-title":"Blood"},{"key":"2464_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37:208\u2013220. https:\/\/doi.org\/10.1016\/j.it.2016.01.004","journal-title":"Trends Immunol"},{"key":"2464_CR10","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1172\/JCI80006","volume":"125","author":"S Ugel","year":"2015","unstructured":"Ugel S, De Sanctis F, Mandruzzato S, Bronte V (2015) Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Investig 125:3365\u20133376. https:\/\/doi.org\/10.1172\/JCI80006","journal-title":"J Clin Investig"},{"key":"2464_CR11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","volume":"169","author":"S Chevrier","year":"2017","unstructured":"Chevrier S, Levine JH, Zanotelli VRT et al (2017) An immune atlas of clear cell renal cell carcinoma. Cell 169:736\u2013738.e18. https:\/\/doi.org\/10.1016\/j.cell.2017.04.016","journal-title":"Cell"},{"key":"2464_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.005","author":"J Wagner","year":"2019","unstructured":"Wagner J, Rapsomaniki MA, Chevrier S et al (2019) A single-cell atlas of the tumor and immune ecosystem of human breast cancer. Cell. https:\/\/doi.org\/10.1016\/j.cell.2019.03.005","journal-title":"Cell"},{"key":"2464_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","volume":"169","author":"Y Lavin","year":"2017","unstructured":"Lavin Y, Kobayashi S, Leader A et al (2017) Innate Immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169:750\u2013757.e15. https:\/\/doi.org\/10.1016\/j.cell.2017.04.014","journal-title":"Cell"},{"key":"2464_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3324\/haematol.2014.113472","volume":"100","author":"S Riihijarvi","year":"2015","unstructured":"Riihijarvi S, Fiskvik I, Taskinen M et al (2015) Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a nordic phase II trial. Haematologica 100:238\u2013245. https:\/\/doi.org\/10.3324\/haematol.2014.113472","journal-title":"Haematologica"},{"key":"2464_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1440-1827.2008.02268.x","volume":"58","author":"S Hasselblom","year":"2008","unstructured":"Hasselblom S, Hansson U, Sigurdardottir M et al (2008) Expression of CD68 tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. Pathol Int 58:529\u2013532. https:\/\/doi.org\/10.1111\/j.1440-1827.2008.02268.x","journal-title":"Pathol Int"},{"key":"2464_CR16","doi-asserted-by":"publisher","first-page":"30347","DOI":"10.1038\/srep30347","volume":"6","author":"L Shen","year":"2016","unstructured":"Shen L, Li H, Shi Y et al (2016) M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma. Sci Rep 6:30347. https:\/\/doi.org\/10.1038\/srep30347","journal-title":"Sci Rep"},{"key":"2464_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2015.10.007","volume":"380","author":"D Aldinucci","year":"2016","unstructured":"Aldinucci D, Celegato M, Casagrande N (2016) Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance. Cancer Lett 380:243\u2013252. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.007","journal-title":"Cancer Lett"},{"key":"2464_CR18","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","volume":"122","author":"P Greaves","year":"2013","unstructured":"Greaves P, Clear A, Owen A et al (2013) Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood 122:2856\u20132863. https:\/\/doi.org\/10.1182\/blood-2013-06-508044","journal-title":"Blood"},{"key":"2464_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP et al (2010) Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362:875\u2013885. https:\/\/doi.org\/10.1056\/NEJMoa0905680","journal-title":"N Engl J Med"},{"key":"2464_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/annonc\/mdr157","volume":"23","author":"D Azambuja","year":"2012","unstructured":"Azambuja D, Natkunam Y, Biasoli I et al (2012) Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. Ann Oncol 23:736\u2013742. https:\/\/doi.org\/10.1093\/annonc\/mdr157","journal-title":"Ann Oncol"},{"key":"2464_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3324\/haematol.2015.124008","volume":"100","author":"R Kridel","year":"2015","unstructured":"Kridel R, Steidl C, Gascoyne RD (2015) Tumor-associated macrophages in diffuse large B-cell lymphoma. Haematologica 100:143\u2013145. https:\/\/doi.org\/10.3324\/haematol.2015.124008","journal-title":"Haematologica"},{"key":"2464_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1189\/jlb.5MA1116-457R","volume":"102","author":"M Roussel","year":"2017","unstructured":"Roussel M, Ferrell PB, Greenplate AR et al (2017) Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow. J Leukoc Biol 102:437\u2013447. https:\/\/doi.org\/10.1189\/jlb.5MA1116-457R","journal-title":"J Leukoc Biol"},{"key":"2464_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cyto.a.22067","volume":"81","author":"HG Fienberg","year":"2012","unstructured":"Fienberg HG, Simonds EF, Fantl WJ et al (2012) A platinum-based covalent viability reagent for single-cell mass cytometry. Cytom A 81:467\u2013475. https:\/\/doi.org\/10.1002\/cyto.a.22067","journal-title":"Cytom A"},{"key":"2464_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/cyto.a.22271","volume":"83","author":"R Finck","year":"2013","unstructured":"Finck R, Simonds EF, Jager A et al (2013) Normalization of mass cytometry data with bead standards. Cytom A 83:483\u2013494. https:\/\/doi.org\/10.1002\/cyto.a.22271","journal-title":"Cytom A"},{"key":"2464_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymeth.2015.05.008","volume":"82","author":"KE Diggins","year":"2015","unstructured":"Diggins KE, Ferrell PB, Irish JM (2015) Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data. Methods 82:55\u201363. https:\/\/doi.org\/10.1016\/j.ymeth.2015.05.008","journal-title":"Methods"},{"key":"2464_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/978-1-4939-9454-0_14","volume":"1989","author":"M Roussel","year":"2019","unstructured":"Roussel M, Bartkowiak T, Irish JM (2019) Picturing polarized myeloid phagocytes and regulatory cells by mass cytometry. Methods Mol Biol 1989:217\u2013226. https:\/\/doi.org\/10.1007\/978-1-4939-9454-0_14","journal-title":"Methods Mol Biol"},{"key":"2464_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/0471142956.cy1017s53","author":"N Kotecha","year":"2010","unstructured":"Kotecha N, Krutzik PO, Irish JM (2010) Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom. https:\/\/doi.org\/10.1002\/0471142956.cy1017s53","journal-title":"Curr Protoc Cytom"},{"key":"2464_CR28","doi-asserted-by":"publisher","first-page":"e1486950","DOI":"10.1080\/2162402X.2018.1486950","volume":"7","author":"P Gravelle","year":"2018","unstructured":"Gravelle P, P\u00e9ricart S, Tosolini M et al (2018) EBV infection determines the immune hallmarks of plasmablastic lymphoma. Oncoimmunology 7:e1486950. https:\/\/doi.org\/10.1080\/2162402X.2018.1486950","journal-title":"Oncoimmunology"},{"key":"2464_CR29","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1158\/0008-5472.CAN-17-2344","volume":"78","author":"W Vermi","year":"2018","unstructured":"Vermi W, Micheletti A, Finotti G et al (2018) slan+ monocytes and macrophages mediate CD20-dependent B-cell lymphoma elimination via ADCC and ADCP. Can Res 78:3544\u20133559. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2344","journal-title":"Can Res"},{"key":"2464_CR30","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen S-H et al (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7:12150. https:\/\/doi.org\/10.1038\/ncomms12150","journal-title":"Nat Commun"},{"key":"2464_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1164\/rccm.201204-0636OC","volume":"186","author":"P-H Feng","year":"2012","unstructured":"Feng P-H, Lee K-Y, Chang Y-L et al (2012) CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. Am J Respir Crit Care Med 186:1025\u20131036. https:\/\/doi.org\/10.1164\/rccm.201204-0636OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2464_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","volume":"136","author":"F Zhao","year":"2012","unstructured":"Zhao F, Hoechst B, Duffy A et al (2012) S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 136:176\u2013183. https:\/\/doi.org\/10.1111\/j.1365-2567.2012.03566.x","journal-title":"Immunology"},{"key":"2464_CR33","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1172\/JCI67580","volume":"123","author":"X Chen","year":"2013","unstructured":"Chen X, Eksioglu EA, Zhou J et al (2013) Induction of myelodysplasia by myeloid-derived suppressor cells. J Clin Investig 123:4595\u20134611. https:\/\/doi.org\/10.1172\/JCI67580","journal-title":"J Clin Investig"},{"key":"2464_CR34","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.18632\/oncotarget.24146","volume":"9","author":"P-H Feng","year":"2018","unstructured":"Feng P-H, Yu C-T, Chen K-Y et al (2018) S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB. Oncotarget 9:7631\u20137643. https:\/\/doi.org\/10.18632\/oncotarget.24146","journal-title":"Oncotarget"},{"key":"2464_CR35","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","volume":"131","author":"F Vari","year":"2018","unstructured":"Vari F, Arpon D, Keane C et al (2018) Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood 131:1809\u20131819. https:\/\/doi.org\/10.1182\/blood-2017-07-796342","journal-title":"Blood"},{"key":"2464_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1182\/bloodadvances.2018020602","volume":"3","author":"R McCord","year":"2019","unstructured":"McCord R, Bolen CR, Koeppen H et al (2019) PD-L1 and tumor-associated macrophages in de novo DLBCL. Blood Adv 3:531\u2013540. https:\/\/doi.org\/10.1182\/bloodadvances.2018020602","journal-title":"Blood Adv"},{"key":"2464_CR37","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","volume":"130","author":"CD Carey","year":"2017","unstructured":"Carey CD, Gusenleitner D, Lipschitz M et al (2017) Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood 130:2420\u20132430. https:\/\/doi.org\/10.1182\/blood-2017-03-770719","journal-title":"Blood"},{"key":"2464_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","volume":"132","author":"FZ Cader","year":"2018","unstructured":"Cader FZ, Schackmann RCJ, Hu X et al (2018) Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment. Blood 132:825\u2013836. https:\/\/doi.org\/10.1182\/blood-2018-04-843714","journal-title":"Blood"},{"key":"2464_CR39","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.celrep.2019.01.085","volume":"26","author":"Z-Z Yang","year":"2019","unstructured":"Yang Z-Z, Kim HJ, Villasboas JC et al (2019) Mass cytometry analysis reveals that specific intratumoral CD4+ T cell subsets correlate with patient survival in follicular lymphoma. Cell Rep 26:2178\u20132193.e3. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.085","journal-title":"Cell Rep"},{"key":"2464_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cyto.b.21498","volume":"92","author":"CE Wogsland","year":"2017","unstructured":"Wogsland CE, Greenplate AR, Kolstad A et al (2017) Mass cytometry of follicular lymphoma tumors reveals intrinsic heterogeneity in proteins including HLA-DR and a deficit in nonmalignant plasmablast and germinal center B-cell populations. Cytom B Clin Cytom 92:79\u201387. https:\/\/doi.org\/10.1002\/cyto.b.21498","journal-title":"Cytom B Clin Cytom"},{"key":"2464_CR41","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/cyto.a.23919","volume":"9","author":"MD Nissen","year":"2019","unstructured":"Nissen MD, Kusakabe M, Wang X et al (2019) Single cell phenotypic profiling of 27 DLBCL cases reveals marked intertumoral and intratumoral heterogeneity. Cytom A 9:2579. https:\/\/doi.org\/10.1002\/cyto.a.23919","journal-title":"Cytom A"},{"key":"2464_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cyto.b.21481","volume":"92","author":"N Leelatian","year":"2017","unstructured":"Leelatian N, Doxie DB, Greenplate AR et al (2017) Single cell analysis of human tissues and solid tumors with mass cytometry. Cytom B Clin Cytom 92:68\u201378. https:\/\/doi.org\/10.1002\/cyto.b.21481","journal-title":"Cytom B Clin Cytom"},{"key":"2464_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14730","author":"AM Mistry","year":"2018","unstructured":"Mistry AM, Greenplate AR, Ihrie RA, Irish JM (2018) Beyond the message: advantages of snapshot proteomics with single-cell mass cytometry in solid tumors. FEBS J. https:\/\/doi.org\/10.1111\/febs.14730","journal-title":"FEBS J"},{"key":"2464_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen C, Wang HAO, Schapiro D et al (2014) Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 11:417\u2013422. https:\/\/doi.org\/10.1038\/nmeth.2869","journal-title":"Nat Methods"},{"key":"2464_CR45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cyto.a.23053","volume":"91","author":"Q Chang","year":"2017","unstructured":"Chang Q, Ornatsky OI, Siddiqui I et al (2017) Imaging mass cytometry. Cytom A 91:160\u2013169. https:\/\/doi.org\/10.1002\/cyto.a.23053","journal-title":"Cytom A"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-019-02464-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:29:32Z","timestamp":1610065772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-019-02464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s00262-019-02464-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jonathan M. Irish was a co-founder and was a board member of Cytobank Inc. and received research support from Incyte Corp, Janssen, and Pharmacyclics. The authors declare that there are no other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Sample collection was performed in France (Rennes [all samples except HL #1, #2, #3, and #4] and through the CeVi_collection [HL #1, #2, #3, and #4]). CyTOF analysis was performed in Nashville, TN, USA by Mikael Roussel during a postdoctoral position in Jonathan Irish\u2019s Lab at Vanderbilt University. Data analysis were performed in both sites (Rennes and Nashville). Multiplex IHC was performed in Toulouse (France).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research sites"}},{"value":"Samples were obtained under French legal guidelines and fulfilled the requirements of the University Hospital of Rennes institutional ethics committee for samples collected in Rennes (CRB) [approval number DC-2008-630 and DC-2016-2565] and of the Comit\u00e9 de Protection des Personnes for samples collected through the Cevi collection [approval number DC-2013-1783].","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and ethical standards"}},{"value":"Tissue from patients was acquired with informed consent in accordance with local institutional review and the Declaration of Helsinki.\u00a0A written consent was obtained from patients before qualification for research in the CRB or the CeVI collection. The consent was for the use of their specimens and data for research and for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}